46 results on '"Dick, Alexej"'
Search Results
2. Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability
3. Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors
4. Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells.
5. Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities
6. Discovery of novel brain permeable human ACSS2 inhibitors for blocking breast cancer brain metastatic growth
7. Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid Modulators
8. Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators
9. Discovery of low‐molecular‐weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability.
10. From design to biological mechanism evaluation of phenylalanine-bearing HIV-1 capsid inhibitors targeting a vital assembly interface
11. The discovery and design of novel HIV-1 capsid modulators and future perspectives
12. Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators
13. Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators
14. Design, Synthesis and Structure—Activity Relationships of Phenylalanine-Containing Peptidomimetics as Novel HIV-1 Capsid Binders Based on Ugi Four-Component Reaction
15. Discovery of novel 1,2,4‐triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein
16. Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulators.
17. Copper Modulates the Catalytic Activity of Protein Kinase CK2
18. Clade-Specific Alterations within the HIV-1 Capsid Protein with Implications for Nuclear Translocation
19. Structural and biochemical studies of orthomyxovirus nucleoproteins as targets of the antiviral Mx proteins
20. Allelic variations in the interferon-induced human MxA protein affect its antiviral activity against influenza A virus: ID: 187
21. Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors
22. Subtype Differences in the Interaction of HIV-1 Matrix with Calmodulin: Implications for Biological Functions
23. Rapid optimization of the metabolic stability of an HIV-1 capsid inhibitor using a multistep computational workflow
24. New RAD51 Inhibitors to Target Homologous Recombination in Human Cells
25. Additional file 1 of Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators
26. Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein
27. The discovery and design of novel HIV-1 capsid modulators and future perspectives
28. Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulatorsElectronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d3md00134b
29. Rapid Optimization of the Metabolic Stability of a Human Immunodeficiency Virus Type-1 Capsid Inhibitor Using a Multistep Computational Workflow
30. Identification of a glycan cluster in gp120 essential for irreversible HIV-1 lytic inactivation by a lectin-based recombinantly engineered protein conjugate
31. Structure of Myxovirus Resistance Protein A Reveals Intra- and Intermolecular Domain Interactions Required for the Antiviral Function
32. Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities
33. Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities
34. Recent Advances in HIV-1 Gag Inhibitor Design and Development
35. Bioisosteric Replacement as a Tool in Anti-HIV Drug Design
36. Metastable HIV-1 Surface Protein Env Sensitizes Cell Membranes to Transformation and Poration by Dual-Acting Virucidal Entry Inhibitors
37. Field-Based Affinity Optimization of a Novel Azabicyclohexane Scaffold HIV-1 Entry Inhibitor
38. Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors
39. Effects of allelic variations in the human myxovirus resistance protein A on its antiviral activity
40. Chemical optimization of macrocyclic HIV-1 inactivators for improving potency and increasing the structural diversity at the triazole ring
41. “Pseudosubstrate Envelope”/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand Efficiency
42. ID: 187
43. Role of Nucleotide Binding and GTPase Domain Dimerization in Dynamin-like Myxovirus Resistance Protein A for GTPase Activation and Antiviral Activity
44. Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein.
45. ID: 187: Allelic variations in the interferon-induced human MxA protein affect its antiviral activity against influenza A virus.
46. Discovery of novel brain permeable human ACSS2 inhibitors for blocking breast cancer brain metastatic growth.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.